Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Arizona Governor Signs Workers' Compensation Opioid Legislation
Arizona Governor Signs Workers' Compensation Opioid Legislation
Kentucky Legislature Passes Workers' Comp Reform Legislation
Kentucky Legislature Passes Workers' Compensation Reform Legislation
Risk & Insurance: The Case Manager's Many Hats
Nurse case managers act as a resource of knowledge, assistance and support for injured workers and everyone involved in their care.
Florida Governor Signs Opioid Legislation
Florida governor signs legislation aimed at combatting the opioid epidemic in Florida.
StateWatch: Bill Review March 2018
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the bill review services Genex provides.
StateWatch: Early Spring 2018
Keep current with new legislation and its potential effect on your organization. This regulatory update is for informational purposes only, and provides some key highlights on state initiatives that may impact the services Genex provides.